Skip to main content

Viskase Holdings, Inc.

VISK
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000727510

No open-market purchases or sales by Viskase Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Holders of 5% or more of VISK

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Viskase Holdings, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of VISK
HolderLatest formStakeChangeFirst filedLatest filingFiling
Icahn Carl CSuperinvestorIcahn Capital13D/A93.70%13.4M shares+45.10 ppfrom 48.60%Dec 19, 20245 filingsMar 27, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

5 Schedule 13D and 13G filings on Viskase Holdings, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on VISK
Filed (ET)FilerFormStakeChangeEvent dateFiling
Mar 27, 20267:48 PM ETIcahn Carl Cand 2 othersSuperinvestorIcahn Capital13D/A93.70%13.4M shares+45.10 ppfrom 48.60%Mar 25, 2026SEC
Jan 30, 20266:02 PM ETIcahn Carl Cand 2 othersSuperinvestorIcahn Capital13D/A48.60%36.1M shares0.00 ppfrom 48.60%Jan 30, 2026SEC
Oct 24, 20254:14 PM ETIcahn Carl Cand 2 othersSuperinvestorIcahn Capital13D/A48.60%36.1M shares0.00 ppfrom 48.60%Oct 24, 2025SEC
Jun 23, 20258:19 AM ETIcahn Carl Cand 2 othersSuperinvestorIcahn Capital13D/A48.60%36.1M shares0.00 ppfrom 48.60%Jun 20, 2025SEC
Dec 19, 20244:30 PM ETIcahn Carl Cand 9 othersSuperinvestorIcahn Capital13D/A48.60%36.1M shares–Dec 19, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Viskase Holdings, Inc. shares.

No Form 144 notices for Viskase Holdings, Inc. are on file.